KPV

KPV is a naturally occurring tripeptide composed of the amino acids lysine, proline and valine. It is derived from alpha-melanocyte-stimulating hormone (α-MSH) and has attracted significant scientific interest for its potential anti-inflammatory and immunomodulatory properties. Compared with the parent hormone, KPV is believed to offer greater stability while retaining many of its biological activities, making it an important area of ongoing research.

Chemical Identifiers

• CAS Number: 67727-97-3
• Molecular Formula: C₁₆H₃₀N₄O₄
• PubChem CID: 125672
• ChEMBL: CHEMBL3235483
• ChemSpider: 111779
• DrugBank: DB05479

Areas of Research Interest

Current preclinical and laboratory research is investigating KPV for its potential to:

• Modulate inflammatory signalling pathways.
• Support normal intestinal barrier function in experimental models.
• Promote tissue repair following inflammatory injury.
• Reduce markers associated with oxidative stress.
• Influence immune signalling without broadly suppressing normal immune function.
• Demonstrate antimicrobial activity against selected microorganisms in laboratory studies.

Although these findings are encouraging, further research is required to determine their relevance and safety in humans.

Proposed Mechanisms Under Investigation

NF-κB Modulation

Research suggests KPV may influence the NF-κB signalling pathway, a key regulator of inflammatory responses. By modulating this pathway, KPV has been shown in experimental models to reduce the production of certain pro-inflammatory mediators.

PepT1 Cellular Transport

Studies indicate that KPV may enter cells via the PepT1 peptide transporter, particularly within the gastrointestinal tract. This transport mechanism is an active area of investigation for understanding peptide delivery during inflammatory processes.

MAPK Signalling

Experimental research has shown that KPV may influence MAPK signalling pathways, including ERK and p38 MAPK, both of which play important roles in cellular responses to inflammation and oxidative stress.

Oxidative Stress

Laboratory studies suggest KPV may reduce the production of reactive oxygen species (ROS) and help protect cells from oxidative damage, although further investigation is required.

Current Research Applications

Scientists are exploring KPV in a variety of experimental settings, including:

• Gastrointestinal inflammation and intestinal barrier research.
• Skin biology and inflammatory skin models.
• Immune regulation and inflammatory signalling.
• Tissue repair and wound healing models.
• Oxidative stress and cellular protection.
• Microbiome and antimicrobial research.

These remain areas of active scientific investigation and should not be interpreted as established therapeutic uses.

Summary

KPV continues to generate considerable interest within the scientific community because of its selective anti-inflammatory properties demonstrated in preclinical research. Its ability to influence multiple biological pathways without acting as a broad immunosuppressant makes it an important peptide for continued laboratory investigation. While early findings are promising, robust clinical studies are still needed to fully understand its safety, effectiveness and potential future applications.

Research Disclaimer

For Research Use Only. Not intended for human consumption, diagnosis, treatment, cure or prevention of any disease. Products supplied by Hybrid 2.0 are intended strictly for laboratory and scientific research purposes. Any information provided is for educational and scientific discussion only and should not be interpreted as medical advice or evidence of clinical efficacy.